|
MDS Inc. (TSX: MDS; NYSE: MDZ) is a global life sciences company with U.S.$1.1 billion in net revenues that provides market-leading products and services to customers for the development of drugs and diagnosis and treatment of disease. MDS is a leading global provider of analytical instruments, medical isotopes for molecular imaging, radiotherapeutics and sterilization technologies, and pharmaceutical contract research. MDS products and services reach people in more than 62 countries around the world with 95 percent of revenues from global markets. MDS continues to strengthen the company's position as a leading innovator in global life sciences markets. MDS Nordion is one of MDS's core business units.
Annual Reports
|
